Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species

Biomedicine and Pharmacotherapy

Volumn 64, Issue 4, 2010, Pages 264-270

  Hwang, Jung Me ^a   Cho, Jin Sook ^b   Kim, Tae Hyeon ^c   Lee, Young Ik ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Molecular Cancer Research Division   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

Author keywords

Apoptosis; Concanavalin A; Cytoprotective effect; Ellagic acid; Mitochondrial depolarization; Reactive oxygen species

Indexed keywords

BUTYLATED HYDROXYANISOLE; CONCANAVALIN A; ELLAGIC ACID; GLUTATHIONE; MENADIONE; REACTIVE OXYGEN METABOLITE; ROTENONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA FRAGMENTATION; HEPATITIS; HUMAN; HUMAN CELL; LIVER FAILURE; LIVER NECROSIS; LIVER PROTECTION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CELL LINE; CONCANAVALIN A; CYTOPROTECTION; ELLAGIC ACID; GLUTATHIONE; HEPATOCYTES; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MITOCHONDRIA, LIVER; NECROSIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VITAMIN K 3;

EID: 77952322983     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.06.013     Document Type: Article

References (13)

1. Loguercio C., Girolamo V., Sio De, Truccilo C., Asciore A., Baldi F., et al. Non-alcoholic fatty liver disease in an area of Southern Italy; main clinical, histological and pathophysiological aspects. J Hepatol 2001, 35:568-574.
2. Kirkland R.A., Francklin J.L. Bax, reactive oxygen and cytochrome c release in neuronal apoptosis. Ant Red Sig 2003, 5:589-596.
3. Zamzami N., Susin S.A., Marchetti P., Hirsh H., Gomez-Monterrey I., Castede M., et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1996, 183:1533-1544.
4. Inoue M., Sato F.F., Nishikawa M., Park A.M., Kira Y., Imada I. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003, 10:2495-2505.
5. Carmody R.J., Cotter T.G. Signaling apoptosis; a radical approach. Redox Reprod 2001, 6:77-90.
6. Bernardi P., Vassaneli S., Veronese P., Colonna R., Szabo I., Zoratti M. Modulation of the mitochondrial permeability transition pore. J Biol Chem 1992, 267:2934-2939.
7. Chauuin C., Oliveria F., Ronot X., Fontaine E. Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. J Biol chem 2001, 276:41394-41398.
8. Maeda S., Chang L., Li Z.W., Luo J.L., Leffet H.L., Karin M. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNF-α. Immunity 2003, 19:725-737.
9. Mandal S., Ahuoia A., Shivapurkar N.M., Cheng S.J., Groopman J.D., Stoner G.D. Inhibition of aflatoxin B1 mutagenesis in Salmonella tyhpimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Carcinogenesis 1997, 8(11):1651-1656.
10. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNF-α induced death and sustained JNK activation by inhibiting MAPK phosphatas. Cell 2004, 120:649-661.
11. Sies H. Antioxidants in disease mechanisms and therapy. 1997, Academic Press, San Diego, USA.
12. Gopalakrishna R., Gandimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 2002, 132:3818S-3823S.
13. Gumpricht E., Dahl R., Devereaux M.W., Sokol R.J. β-carotene pervents bile acid-induced cytotoxicity in the rat hepatocyte: evidence for an antioxidant and anti-apoptotic status of β-carotene in vitro. Ped Res 2004, 55:814-821.